Intriguingly, reasons of m6A dysregulation in CSCs are different among various types of cancer, considering the roles of FTO, ALKBH5, and METTL3 in glioblastoma stem cells [24, 25] and of METTL14 and FTO in leukemia stem cells [26, 27]. Here, METTL14 is linked to cancer.